Ophthalmologica

Original Paper

Clinicopathological Study of the Idiopathic Macular Hole: Comparison of Epiretinal Membrane Peeling and Internal Limiting Membrane Peeling

Kuo H.-K.a,c · Lin J.-W.b · Kao M.-L.a · Liu C.-C.a

Author affiliations

Departments of aOphthalmology and bPathology, Chang-Gung Memorial Hospital, Kaohsiung, and cChang-Gung University, Taoyuan, Taiwan, ROC

Keywords: Macular holePathologyEpiretinal membrane peelingInternal limiting membrane peelingIndocyanine green

Related Articles for ""
Ophthalmologica 2004;218:31–35
https://doi.org/10.1159/000074564

Log in to MyKarger to check if you already have access to this content.




Forgot your password
Sign up to MyKarger

Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more
CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!


If you would like to redeem your KAB credit, please log in.

Save over 20% compared to the individual article price.

Learn more

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00

Select

Subscribe

  • Access to all articles of the subscribed year(s) guaranteed for 5 years
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates

Select
* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview
Abstract of Original Paper

Received: January 02, 2003
Accepted: June 06, 2003
Published online: December 22, 2003
Issue release date: January – February

Number of Print Pages: 5
Number of Figures: 4
Number of Tables: 1

ISSN: 0030-3755 (Print)
eISSN: 1423-0267 (Online)

For additional information: https://www.karger.com/OPH

Abstract

The aim of this study was to identify the internal limiting membrane (ILM) and epiretinal membrane (ERM) harvested during macular hole surgery under light microscopy and electron microscopy and to evaluate the difference in specimen loss rate with and without the aid of indocyanine green (ICG) staining. Thirty-two consecutive patients (34 eyes) with stage 2–4 macular holes were included. ERM peeling (macular hole with ERM) or ILM peeling (macular hole without ERM), with or without the use of ICG, was used during macular hole surgery with vitrectomy. There were 26 specimens for pathology; 12 specimens (46%) were lost during processing. ICG staining did not reduce the specimen loss rate. The specimens harvested from intentional ILM peeling displayed a smooth, translucent ILM. The specimens harvested from ERM peeling showed moderate cellular proliferation abutting on the ILM, and all specimens had an ILM. The pathological findings confirmed the clinical observations in all the cases studied. The ILM appeared in all specimens harvested by ERM peeling during macular hole surgery. ICG staining does not alter the specimen loss rate during pathological processing.

© 2004 S. Karger AG, Basel



Related Articles:

References

  1. Chewn EY, Sperduto RD, Hiller R, Nowroozi L, Seigel D, Yanuzzi L, Burton TC, Seddon JM, Gragoudas ES, Haller JA, Blair NP, Farber M: Clinical course of macular holes. Arch Ophthalmol 1999;117:242–246.
    External Resources
  2. Johnson RN, Gass DM: Idiopathic macular holes. Ophthalmology 1988;95:917–924.
    External Resources
  3. Kelly NE, Wendle RT: Vitreous surgery for idiopathic macular holes. Arch Ophthalmol 1991;109:654–659.
    External Resources
  4. Liggett PE, Skolik DS, Horio B, Saito Y, Alfaro V, Mieler W: Human autologous serum for the treatment of full-thickness macular holes. Ophthalmology 1995;102:1071–1076.
    External Resources
  5. Tornambe PE, Poliner LS, Grote K: Macular hole surgery without face-down positioning. Retina 1997;17:179–185.
    External Resources
  6. Ezra E, Aylward WG, Gregor ZJ: Membranectomy and autologous serum for the retreatment of full-thickness macular holes. Arch Ophthalmol 1997;115:1276–1280.
    External Resources
  7. Olsen TW, Sternberg P, Capone A, Martin DF, Lim JI, Grossniklaus HE, Aaberg TM: Macular hole surgery using thrombin-activated fibrinogen and selective removal of the internal limiting membrane. Retina 1998;18:322–329.
    External Resources
  8. Park DW, Sipperley JO, Sneed SR, Dugel PU, Jacobsen J: Macular hole surgery with internal limiting membrane peeling and intravitreous air. Ophthalmology 1999;106:1392–1398.
    External Resources
  9. Brooks HL: Macular hole surgery with and without internal limiting membrane peeling. Ophthalmology 2000;107:1939–1949.
    External Resources
  10. Mester V, Kuhn F: Internal limiting membrane removal in the management of full-thickness macular holes. Am J Ophthalmol 2000;129:769–777.
    External Resources
  11. Smiddy WE, Feuer W, Cordahi G: Internal limiting membrane peeling in macular hole surgery. Ophthalmology 2001;108:1471–1478.
    External Resources
  12. Kadonosono K, Itoh N, Uchio E, Nakamura S, Ohno S: Staining of internal limiting membrane in macular hole surgery. Arch Ophthalmol 2000;118:1116–1118.
    External Resources
  13. Kwok AH, Li WY, Pang CP, Lai TYY, Yam GHF, Chan NR, Lam DSC: Indocyanine green staining and removal of internal limiting membrane in macular hole surgery: Histology and outcome. Am J Ophthalmol 2001;132:178–183.
    External Resources
  14. Da Mata AP, Burk SE, Riemann CD, Rosa RH, Snyder ME, Petersen MR, Foster RE: Indocyanine green-assisted peeling of the retinal internal limiting membrane during vitrectomy surgery for macular hole repair. Ophthalmology 2001;108:1187–1192.
    External Resources
  15. Gass JD. Stereoscopic Atlas of Macular Disease, ed 2. St Louis, Mosby, 1997, vol 2, pp 917–918.
  16. Cheng L, Freeman WR, Ozerdem U, Song MK, Azen SP: Prevalence, correlates, and natural history of epiretinal membranes surrounding idiopathic macular holes. Ophthalmology 2000;107:853–859.
    External Resources
  17. Guyer DR, Green WR, Bustros SD, Fine SL: Histopathologic features of idiopathic macular holes and cysts. Ophthalmology 1990;97:1045–1051.
    External Resources
  18. Smiddy W, Michels RG, Green WR: Morphology, pathology, and surgery of idiopathic vitreoretinal macular disorders. Retina 1990;10:288–296.
    External Resources
  19. Messmer EM, Heidenkummer HP, Kampik A: Ultrastructure of epiretinal membranes associated with macular holes. Graefe’s Arch Clin Exp Ophthalmol 1998;236:248–254.
  20. Green WR: Retina; in Spencer WH (ed): Ophthalmic Pathology, ed 3. Philadelphia, Saunders Co, 1985, vol 2, chapt 8.
  21. Yoon HS, Brooks HL, Capone A, L’Hernault NL, Grossniklaus HE: Ultrastructural features of tissue removed during idiopathic macular hole surgery. Am J Ophthalmol 1996;122:67–75.
    External Resources

Article / Publication Details

First-Page Preview
Abstract of Original Paper

Received: January 02, 2003
Accepted: June 06, 2003
Published online: December 22, 2003
Issue release date: January – February

Number of Print Pages: 5
Number of Figures: 4
Number of Tables: 1

ISSN: 0030-3755 (Print)
eISSN: 1423-0267 (Online)

For additional information: https://www.karger.com/OPH

Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

Article Tools
Article Details

2004, Vol.218, No. 1

January – February

Article

Recommend This
Additional Information

The material in this article was presented at the annual meeting of the ARVO in Fort Lauderdale, Fla., USA, on May 7, 2002.
TOP